NYSE · SIC 5122
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions. The RxTS segment offers CoverMyMeds solution to help patients get the medications.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $238.2B | $264.0B | $276.7B | $309.0B | $359.1B | $403.4B |
| Gross profit | $12.1B | $13.1B | $12.4B | $12.8B | $13.3B | $14.6B |
| Operating income | -$5.0B | $2.0B | $4.4B | $3.9B | $4.4B | $6.2B |
| Net income | -$4.5B | $1.1B | $3.6B | $3.0B | $3.3B | $4.8B |
| Diluted EPS | -$28.26 | $7.23 | $25.03 | $22.39 | $25.72 | $38.38 |
| Operating cash flow | $4.5B | $4.4B | $5.2B | $4.3B | $6.1B | $6.2B |
| Free cash flow | $4.1B | $4.0B | $4.8B | $3.9B | $5.5B | $5.7B |
| Gross margin | 5.1% | 5.0% | 4.5% | 4.2% | 3.7% | 3.6% |
| Operating margin | -2.1% | 0.8% | 1.6% | 1.3% | 1.2% | 1.5% |
| Net margin | -1.9% | 0.4% | 1.3% | 1.0% | 0.9% | 1.2% |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $79.3B | $93.7B | $95.3B | $90.8B | $97.8B | $103.2B | $106.2B | $96.3B |
| Gross profit | $3.2B | $3.2B | $3.3B | $3.6B | $3.3B | $3.5B | $3.7B | $4.0B |
| Operating income | $1.0B | $578.0M | $1.2B | $1.6B | $1.0B | $1.4B | $1.6B | $2.1B |
| Net income | $915.0M | $241.0M | $879.0M | $1.3B | $784.0M | $1.1B | $1.2B | $1.7B |
| Diluted EPS | $7.00 | $1.87 | $6.95 | $9.90 | $6.25 | $8.92 | $9.59 | $13.62 |
| Operating cash flow | -$1.4B | $2.1B | -$2.4B | $7.7B | -$918.0M | $2.4B | $1.2B | $3.4B |
| Free cash flow | -$1.5B | $2.0B | -$2.5B | $7.6B | -$1.0B | $2.3B | $1.1B | $3.3B |
| Gross margin | 4.0% | 3.5% | 3.4% | 4.0% | 3.4% | 3.4% | 3.5% | 4.2% |
| Operating margin | 1.3% | 0.6% | 1.3% | 1.8% | 1.1% | 1.4% | 1.5% | 2.2% |
| Net margin | 1.2% | 0.3% | 0.9% | 1.4% | 0.8% | 1.1% | 1.1% | 1.7% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-07 | TYLER BRIAN S.· Chief Executive Officer | Sale | 8,463 | $793.56 | $6.7M | filing |
| 2026-06-17 | TYLER BRIAN S.· Chief Executive Officer | Sale | 8,463 | $775.13 | $6.6M | filing |
| 2026-06-09 | TYLER BRIAN S.· Chief Executive Officer | Sale | 4,929 | $763.00 | $3.8M | filing |
| 2026-06-05 | Rutledge Napoleon B JR· SVP, Controller & CAO | Sale | 133 | $764.00 | $101,612.00 | filing |
| 2026-06-02 | Rodgers Thomas L· EVP, Chief Strategy & BDO | Sale | 699 | $735.27 | $513,953.73 | filing |
| 2026-06-01 | Smith LeAnn B· EVP & Chief HR Officer | Sale | 1,810 | $735.50 | $1.3M | filing |
| 2026-06-01 | Rodgers Thomas L· EVP, Chief Strategy & BDO | Sale | 123 | $735.50 | $90,466.50 | filing |
| 2026-05-26 | Lau Michele· EVP and Chief Legal Officer | Sale | 3,550 | $761.09 | $2.7M | filing |
| 2026-05-26 | Rodgers Thomas L· EVP, Chief Strategy & BDO | Sale | 2,388 | $761.09 | $1.8M | filing |
| 2026-05-23 | TYLER BRIAN S.· Chief Executive Officer | Tax withholding | 1,831 | $766.08 | $1.4M | filing |
| 2026-05-23 | Vitalone Britt J.· EVP & CFO | Tax withholding | 581 | $766.08 | $445,092.48 | filing |
| 2026-05-23 | Smith LeAnn B· EVP & Chief HR Officer | Tax withholding | 268 | $766.08 | $205,309.44 | filing |
| 2026-05-23 | Rodgers Thomas L· EVP, Chief Strategy & BDO | Tax withholding | 234 | $766.08 | $179,262.72 | filing |
| 2026-05-23 | Fraga Francisco· EVP, CIO and CTO | Tax withholding | 54 | $766.08 | $41,368.32 | filing |
| 2026-05-23 | Rutledge Napoleon B JR· SVP, Controller & CAO | Tax withholding | 41 | $766.08 | $31,409.28 | filing |
| 2026-05-23 | Rutledge Napoleon B JR· SVP, Controller & CAO | Option exercise | 136 | $0.00 | $0.00 | filing |
| 2026-05-23 | TYLER BRIAN S.· Chief Executive Officer | Option exercise | 4,579 | $0.00 | $0.00 | filing |
| 2026-05-23 | Vitalone Britt J.· EVP & CFO | Option exercise | 1,476 | $0.00 | $0.00 | filing |
| 2026-05-23 | Smith LeAnn B· EVP & Chief HR Officer | Option exercise | 679 | $0.00 | $0.00 | filing |
| 2026-05-23 | Rodgers Thomas L· EVP, Chief Strategy & BDO | Option exercise | 594 | $0.00 | $0.00 | filing |
| 2026-05-23 | Fraga Francisco· EVP, CIO and CTO | Option exercise | 136 | $0.00 | $0.00 | filing |
| 2026-05-21 | Tyler Brian Scott· Chief Executive Officer | Tax withholding | 1,319 | $766.50 | $1.0M | filing |
| 2026-05-21 | Vitalone Britt J.· EVP & CFO | Tax withholding | 447 | $766.50 | $342,625.50 | filing |
| 2026-05-21 | Lau Michele· EVP and Chief Legal Officer | Tax withholding | 285 | $766.50 | $218,452.50 | filing |
| 2026-05-21 | Smith LeAnn B· EVP & Chief HR Officer | Tax withholding | 209 | $766.50 | $160,198.50 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.